GeneDx and Mirum to provide genetic tests for cholestasis, cataracts or PBD-ZSD
GeneDx and Mirum Pharmaceuticals have partnered to provide no-cost exome sequencing for eligible patients across cholestasis, early-onset cataracts, and PBD-ZSD testing programmes.
The post GeneDx and Mirum to provide genetic tests for cholestasis, cataracts or PBD-ZSD appeared first on Medical Device Network .